|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3169361 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15747647.4 |
| Europos patento paraiškos padavimo data | 2015-07-15 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-05-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-06-19 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/040582 |
| Data | 2015-07-15 |
| (87) | Numeris | WO 2016/011160 |
| Data | 2016-01-21 |
| (30) | Numeris | Data | Šalis |
| 201462024988 P | 2014-07-15 | US |
| (72) |
JUNTTILA, Melissa, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |
| COMPOSITIONS FOR TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS |